AccessPak for HIV PEP Expanded with Kaletra and Loteprednol and Tobramycin
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Loteprednol and Tobramycin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Loteprednol and tobramycin ophthalmic
- AccessPak for HIV PEP Expanded with Kaletra-Loteprednol Etabonate
- AccessPak for HIV PEP Expanded with Kaletra-Loteprednol Eye Drops
- AccessPak for HIV PEP Expanded with Kaletra-Loteprednol Eye Drops 0.2%
- AccessPak for HIV PEP Expanded with Kaletra-Loteprednol Eye Drops 0.5% and 1%
- AccessPak for HIV PEP Expanded with Kaletra-Loteprednol Eye Gel
- Loteprednol and Tobramycin-AccessPak for HIV PEP Expanded with Viracept
- Loteprednol and Tobramycin-Accolate
- Loteprednol and Tobramycin-Accretropin
- Loteprednol and Tobramycin-Accucaine
- Loteprednol and Tobramycin-AccuHist Drops
- Loteprednol and Tobramycin-AccuHist PDX Drops